KRAZATI: payments to doctors
Payments that named KRAZATI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.1M
- Providers
- 6,701
- Transactions
- 17,492
- Average per transaction
- $119
The per-transaction average — $119 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,701 providers the average total is $310, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Mirati Therapeutics, Inc. | $1,995,804 | 96.1% |
| E.r. Squibb & Sons, L.L.C. | $80,204 | 3.9% |